Rockwood Clinic is conducting a research study to test the safety and efficacy of exenatide as a treatment for type 2 diabetic children and adolescents.

Your child may qualify for this study if they:

• Are between ages 10 to 16 years, inclusive
• Have a diagnosis and history of type 2 diabetes
• Are naïve to anti-diabetic agents and being treated with diet and exercise alone or are being treated with metformin, a sulfonylurea, or a combination of both (with or without diet and exercise), for at least 3 months
• Are able to understand and comply with a lifestyle modification program

Your child will receive the following at no charge:

• Study-related physical exams and laboratory tests
• Diabetes education and coaching
• Study medications and supplies

Compensation for time and travel is also provided.  To find out more about this, call (509) 342-3180. 

Principal Investigator

Carol Wysham, M.D. (refer to CTBQ study)